Advantages of Lipid-Lowering Therapy in Cerebral Ischemia: Role of HMG-CoA Reductase Inhibitors

Publisher： Karger

E-ISSN： 1421-9786|11|1|85-95

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.11, Iss.1, 2010-04, pp. : 85-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Direct Vascular Effects of HMG-CoA Reductase Inhibitors

By Laufs U.   Liao J.K.  

Trends in Cardiovascular Medicine, Vol. 10, Iss. 4, 2000-05 ,pp. : 143-148

Elsevier

Access to resources Recommend Favorite

HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis

By Yilmaz A.   Reiss C.   Tantawi O.   Weng A.   Stumpf C.   Raaz D.   Ludwig J.   Berger T.   Steinkasserer A.   Daniel W.G.   Garlichs C.D.  

Atherosclerosis, Vol. 172, Iss. 1, 2004-01 ,pp. : 85-93

Elsevier

Access to resources Recommend Favorite

Effect of HMG-CoA Reductase Inhibition on Vascular Smooth Muscle Cells Extracellular Matrix Production: Role of RhoA

By  

Current Vascular Pharmacology, Vol. 14, Iss. 4, 2016-07 ,pp. : 345-352

Bentham Science Publishers

Access to resources Recommend Favorite

Retrospective, Observation Study: Quantitative and Qualitative Effect of Ezetimibe and HMG-CoA Reductase Inhibitors on LDL-Cholesterol: Are There Disappearance Thresholds for Small, Dense LDL and IDL?

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 2, 2010-06 ,pp. : 143-152

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular prevention with lipid-lowering therapy in elderly

By Philippe F.  

Annales de Cardiologie et d'Angeiologie, Vol. 52, Iss. 4, 2003-08 ,pp. : 246-253

Elsevier

Access to resources Recommend Favorite